Claude C. Warzecha

3.3k total citations · 1 hit paper
22 papers, 2.4k citations indexed

About

Claude C. Warzecha is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Claude C. Warzecha has authored 22 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Claude C. Warzecha's work include RNA Research and Splicing (10 papers), RNA modifications and cancer (7 papers) and RNA Interference and Gene Delivery (5 papers). Claude C. Warzecha is often cited by papers focused on RNA Research and Splicing (10 papers), RNA modifications and cancer (7 papers) and RNA Interference and Gene Delivery (5 papers). Claude C. Warzecha collaborates with scholars based in United States, China and France. Claude C. Warzecha's co-authors include Russ P. Carstens, Yi Xing, Behnam Nabet, Trey K. Sato, John B. Hogenesch, Shihao Shen, James M. Wilson, Rakan El‐Mayta, Michael J. Mitchell and Lili Wang and has published in prestigious journals such as Nature Communications, Nano Letters and The EMBO Journal.

In The Last Decade

Claude C. Warzecha

22 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device

2021 222 citations Sarah J. Shepherd, Claude C. Warzecha et al. Nano Letters profile →

Peers

Countries citing papers authored by Claude C. Warzecha

Since Specialization

Citations

This map shows the geographic impact of Claude C. Warzecha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude C. Warzecha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude C. Warzecha more than expected).

Fields of papers citing papers by Claude C. Warzecha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude C. Warzecha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude C. Warzecha. The network helps show where Claude C. Warzecha may publish in the future.

Co-authorship network of co-authors of Claude C. Warzecha

This figure shows the co-authorship network connecting the top 25 collaborators of Claude C. Warzecha. A scholar is included among the top collaborators of Claude C. Warzecha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude C. Warzecha. Claude C. Warzecha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors 2024 ·Nature Communications ·Xuexiang Han, Junchao Xu, Ying Xu, Mohamad‐Gabriel Alameh, Lulu Xue, Ningqiang Gong, Rakan El‐Mayta, Rohan Palanki, Claude C. Warzecha, Gan Zhao, Andrew E. Vaughan, James M. Wilson, Drew Weissman, Michael J. Mitchell	41
2	Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo 2024 ·Nature Chemistry ·Xuexiang Han, Mohamad‐Gabriel Alameh, Ningqiang Gong, Lulu Xue, Majed Ghattas, (unknown), Junchao Xu, Gan Zhao, Claude C. Warzecha, Marshall S. Padilla, Rakan El‐Mayta, Garima Dwivedi, Ying Xu, Andrew E. Vaughan, James M. Wilson, Drew Weissman, Michael J. Mitchell	44
3	Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution 2024 ·Nature Biomedical Engineering ·Xuexiang Han, Mohamad‐Gabriel Alameh, Ying Xu, Rohan Palanki, Rakan El‐Mayta, Garima Dwivedi, Kelsey L. Swingle, Junchao Xu, Ningqiang Gong, Lulu Xue, Qiangqiang Shi, (unknown), Claude C. Warzecha, James M. Wilson, Drew Weissman, Michael J. Mitchell	22
4	Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression 2022 ·Molecular Therapy — Methods & Clinical Development ·Lili Wang, Claude C. Warzecha, (unknown), Jessica A. Chichester, Peter Bell, Elizabeth L. Buza, Zhenning He, M. Betina Pampena, Julien Couthouis, Sunjay Sethi, Kathleen McKeever, Michael R. Betts, Emil Kakkis, James M. Wilson, Samuel Wadsworth, Barbara Sullivan	19
5	Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9 2021 ·Molecular Therapy ·Lili Wang, Camilo Breton, Claude C. Warzecha, Peter Bell, Hanying Yan, Zhenning He, John White, Yanqing Zhu, Mingyao Li, Elizabeth L. Buza, Derek Jantz, James M. Wilson	48
6	Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device breakdown → 2021 ·Nano Letters ·Sarah J. Shepherd, Claude C. Warzecha, Sagar Yadavali, Rakan El‐Mayta, Mohamad‐Gabriel Alameh, Lili Wang, Drew Weissman, James M. Wilson, David Issadore, Michael J. Mitchell	222
7	Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver 2020 ·Biomaterials Science ·Rui Zhang, Rakan El‐Mayta, Timothy J. Murdoch, Claude C. Warzecha, Margaret M. Billingsley, Sarah J. Shepherd, Ningqiang Gong, Lili Wang, James M. Wilson, Daeyeon Lee, Michael J. Mitchell	175
8	Ldb1 is required for Lmo2 oncogene–induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia 2020 ·Blood ·(unknown), Apratim Mitra, Kairong Cui, Bin Zhao, Seeyoung Choi, (unknown), (unknown), Dalal El‐Khoury, Claude C. Warzecha, Karl Pfeifer, Joyce Hardwick, Keji Zhao, Bryan J. Venters, Utpal P. Davé, Paul E. Love	5
9	HIRA, a DiGeorge Syndrome Candidate Gene, Confers Proper Chromatin Accessibility on HSCs and Supports All Stages of Hematopoiesis 2020 ·Cell Reports ·Chao Chen, Ming-an Sun, Claude C. Warzecha, Mahesh Bachu, Anup Dey, Tiyun Wu, Peter D. Adams, Todd S. Macfarlan, Paul E. Love, Keiko Ozato	13
10	THEMIS enhances TCR signaling and enables positive selection by selective inhibition of the phosphatase SHP-1 2017 ·Nature Immunology ·Seeyoung Choi, Claude C. Warzecha, (unknown), Jan Lee, (unknown), Renaud Lesourne, L. Aravind, Paul E. Love	53
11	Themis2 lowers the threshold for B cell activation during positive selection 2016 ·Nature Immunology ·(unknown), Mukta Deobagkar‐Lele, (unknown), Seeyoung Choi, Shoji Uehara, (unknown), Sophia Bennett, Katherine R. Bull, Tanya L. Crockford, Helen Ferry, Claude C. Warzecha, Marlène Marcellin, Anne Gonzalez de Peredo, Renaud Lesourne, Consuelo Anzilotti, Paul E. Love, Richard J. Cornall	22
12	Ldb1 complexes: the new master regulators of erythroid gene transcription 2013 ·Trends in Genetics ·Paul E. Love, Claude C. Warzecha, LiQi Li	93
13	Dynamic Fluorescent and Luminescent Reporters for Cell-Based Splicing Screens 2012 ·Methods in molecular biology ·Claude C. Warzecha, (unknown), Russ P. Carstens	7
14	Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT) 2012 ·Seminars in Cancer Biology ·Claude C. Warzecha, Russ P. Carstens	109
15	An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition 2010 ·The EMBO Journal ·Claude C. Warzecha, Peng Jiang, (unknown), Kimberly A. Dittmar, Hezhe Lu, Shihao Shen, Wei Guo, Yi Xing, Russ P. Carstens	290
16	The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events 2009 ·RNA Biology ·Claude C. Warzecha, Shihao Shen, Yi Xing, Russ P. Carstens	168
17	ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing 2009 ·Molecular Cell ·Claude C. Warzecha, Trey K. Sato, Behnam Nabet, John B. Hogenesch, Russ P. Carstens	435
18	MADS+: discovery of differential splicing events from Affymetrix exon junction array data 2009 ·Bioinformatics ·Shihao Shen, Claude C. Warzecha, Russ P. Carstens, Yi Xing	30
19	The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle Progression 2008 ·Molecular Cell ·Xiaoyong Zhang, (unknown), Stephen M. Sykes, Charles B Phillips, Claude C. Warzecha, Wenting Zhu, Anastasia Wyce, Alan W. Thorne, Shelley L. Berger, Steven B. McMahon	339
20	Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays 2006 ·RNA ·(unknown), (unknown), (unknown), Claude C. Warzecha, Richard B. Jones, Wallace L. McKeehan, Russ P. Carstens	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact